Compare HOVR & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOVR | MBOT |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.3M | 126.9M |
| IPO Year | 2022 | 2000 |
| Metric | HOVR | MBOT |
|---|---|---|
| Price | $1.69 | $1.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $10.33 | $7.50 |
| AVG Volume (30 Days) | ★ 884.7K | 761.3K |
| Earning Date | 04-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $1.44 |
| 52 Week High | $4.18 | $3.94 |
| Indicator | HOVR | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 38.63 |
| Support Level | $1.67 | $1.44 |
| Resistance Level | $1.91 | $2.21 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 19.77 | 15.87 |
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.